Related Experiment Video
Updated: Jan 23, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in
Di Chen1,2,3, Yangmin Ma4, Peiqi Li5
1Shaanxi Key Laboratory of Chemical Additives for Industry, Shaanxi University of Science and Technology, Xi'an 710021, China. observercd@163.com.
Abstract:
Triple-negative breast cancer (TNBC) lacks major effective target molecules and chemotherapy remains the current main treatment. However, traditional chemotherapy drugs, such as doxorubicin (DOX), cause serious side effects and have a poor prognosis. Piperlongumine (PL), a natural alkaloid, has showed selective anticancer effects and is expected to become a new strategy against TNBC. In our research, cell viability, colony formation, flow cytometry, Western blot, and tumor xenograft model assays were established to evaluate the suppression effect of PL and DOX alone and in combination. Data showed that PL could effectively inhibit cell growth and induce apoptosis in two TNBC cell lines. We also demonstrated for the first time that the combination treatment of PL and DOX synergistically inhibited cell growth and induced apoptosis in TNBC cells. The suppression of STAT3 activation was indicated to be a mechanism of the anticancer effect. Moreover, the effectiveness of this combination was confirmed in a tumor xenograft model. These results revealed that inhibition of the JAK2-STAT3 pathway was a key anticancer mechanism when treated with PL alone or combined with DOX, suggesting that the combination of PL and chemotherapy drugs may be a potential strategy for the clinical treatment of TNBC.
Insights
Piperlongumine (PL) and doxorubicin (DOX) synergistically inhibit triple-negative breast cancer (TNBC) growth by inducing apoptosis. This combination therapy targets the JAK2-STAT3 pathway, offering a promising strategy for TNBC treatment.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Triple-negative breast cancer (TNBC) lacks targeted therapies, with chemotherapy like doxorubicin (DOX) offering limited efficacy and significant side effects.
- Piperlongumine (PL), a natural alkaloid, exhibits selective anticancer properties and presents a potential new strategy for TNBC.
- The JAK2-STAT3 pathway is implicated in cancer progression and represents a potential therapeutic target.
Purpose of the Study:
- To evaluate the efficacy of piperlongumine (PL) and doxorubicin (DOX) alone and in combination against TNBC.
- To elucidate the underlying molecular mechanisms, specifically the role of the JAK2-STAT3 pathway.
- To assess the therapeutic potential of PL-DOX combination in a preclinical TNBC model.
Main Methods:
- Cell viability and colony formation assays were used to assess growth inhibition.
- Flow cytometry was employed to analyze apoptosis induction.
- Western blot analysis was performed to investigate protein expression and pathway activation.
- A tumor xenograft model was utilized to evaluate in vivo efficacy.
Main Results:
- Piperlongumine (PL) demonstrated significant inhibition of TNBC cell growth and induced apoptosis.
- The combination of PL and DOX exhibited synergistic effects, enhancing growth suppression and apoptosis induction in TNBC cells.
- PL, alone or in combination with DOX, suppressed the activation of the JAK2-STAT3 pathway.
- The combination therapy showed significant efficacy in reducing tumor volume in the xenograft model.
Conclusions:
- The combination of piperlongumine (PL) and doxorubicin (DOX) demonstrates synergistic anticancer activity against triple-negative breast cancer (TNBC).
- Inhibition of the JAK2-STAT3 pathway is a key mechanism underlying the efficacy of this combination therapy.
- PL combined with chemotherapy represents a promising therapeutic strategy for clinical application in TNBC treatment.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Feedback Inhibition
Apoptosis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Mechanisms of Retrovirus-induced Cancers

